Abstract. The gene for a microtubule-associated protein (MAP), termed MHP1 (MAP-Homologous Protein 1), was isolated from Saccharomyces cerevisiae by expression cloning using antibodies specific for the Drosophila 205K MAP. MHP1 encodes an essential protein of 1,398 amino acids that contains near its COOH-terminal end a sequence homologous to the microtubule-binding domain of MAP2, MAP4, and tau. While total disruptions are lethal, NH2-terminal deletion mutations of MHP1 are viable, and the expression of the COOH-terminal two-thirds of the protein is sufficient for vegetative growth. Nonviable deletion-disruption mutations of MHP1 can be partially complemented by the expression of the Drosophila 205K MAP. Mhplp binds to microtubules in vitro, and it is the COOH-terminal region containing the tau-homologous motif that mediates microtubule binding. Antibodies directed against a COOH-terminal peptide of Mhplp decorate cytoplasmic microtubules and mitotic spindles as revealed by immunofluorescence microscopy. The overexpression of an NH2-terminal deletion mutation of MHP1 results in an accumulation of largebudded cells with short spindles and disturbed nuclear migration. In asynchronously growing cells that overexpress MHP1 from a multicopy plasmid, the length and number of cytoplasmic microtubules is increased and the proportion of mitotic cells is decreased, while haploid cells in which the expression of MHP1 has been silenced exhibit few microtubules. These results suggest that MHP1 is essential for the formation and/or stabilization of microtubules.
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M
ICROTUBULES (MTs) 1 are involved in a number of essential cellular processes such as cell morphogenesis, intracellular transport, cell motility, and mitosis. Important potential regulators of MT dynamics are the MT-associated proteins (MAPs) (Lee, 1993; Wiche et al., 1991) . Initially MAPs were isolated from neural tissues rich in MTs by means of copurification with polymerized MTs. These neural MAPs, including MAP 1A (Schoenfeld et al., 1989) , MAP 1B (Noble et al., 1989) , MAP2 (Lewis et al., 1988) , and tau (Lee et al., 1988) , were shown to stimulate MT assembly from purified tubulin in vitro (Cleveland et al., 1977; Murphy et al., 1977; Bulinski and Borisy, 1979) . Although these MAPs have been characterized biochemically, their specific functions have not been determined unambiguously.
and, as in the case of tau, a short, acidic COOH-terminal region that is preceded by a basic region containing the MT-binding domain.
The in vivo functions of all the MAPs identified so far remain uncertain, mainly because of the absence of genetic studies. In the isolated case of the Drosophila 205K MAP where such studies were possible, the protein was found not to be essential (Pereira et al., 1992) . A powerful tool to more fully investigate the functions of MAPs is the yeast Saccharomyces cerevisiae, since it is possible to establish genetic interactions between MAPs and tubulin or other cytoskeletal components. A number of laboratories have attempted to identify MAPs in yeast. Their approaches have involved purifying proteins by MT-affinity columns (Barnes et al., 1992) or from cellular structures comprising MTs such as the spindle pole body (SPB) (Kilmartin et al., 1993) and the centromere-binding complex (Jiang et al., 1993) , identifying yeast proteins that crossreact with antibodies against mammalian MAPs (Hasek et al., 1991) , cloning genes complementing cellular defects involving MTs Stearns et al., 1990; McMillan and Tatchell, 1994) , and cloning yeast sequences using PCR with degenerated primers derived from homologous sequences of different species (Hyman et al., 1992) . These strategies led to the identification of CPF5p, a component of the yeast centromere-binding complex, a homologue of mammalian MAP1A and B (Jiang et al., 1993) , and a number of genes encoding proteins that share similarities with motor proteins (Berlin et al., 1990; Meluh and Rose, 1990; Hoyt et al., 1992; Lillie and Brown, 1992; Roof et al., 1992; Li et al., 1993) . In a biochemical approach, Sepl has been identified as an accessory protein in MT function in yeast (Interthal et al., 1995) . A genetic screen for complementation of a temperature-sensitive allele of the 13-tubulin gene led to the identification of STU1, a gene encoding a protein with a predicted size of 174 kD and no significant homology to known proteins (Pasqualone and Huffaker, 1994) .
We chose to search for yeast proteins that cross-react with antibodies directed against the Drosophila 205K MAP, leading to the discovery of a novel essential MAP gene, MHP1 (MAP Homologous Protein 1). We present evidence that the product of this gene, Mhplp, interacts with MTs and that mutations in MHP1 influence MT structure and function during interphase and mitosis.
Materials and Methods

Strains and Microbiological Techniques
All yeast strains used in this study are listed in Table I . Genetic manipulations and growth media were standard (Sherman et al., 1986; Rose et al., 1990) .
Cloning of MHP1
A partial sequence of the MHP1 gene was cloned by screening a kgtll eDNA expression library from S. cerevisiae (kindly provided by Dr. B. Altman, University of Bern, Switzerland). 20,000 plaques were screened and plated in Y1090r-host cells to a plaque density of 1,000-2,000 plaques per plate. Plates were incubated at 42"C for 4 h, or until very small plaques were visible, then overlaid with nitrocellulose filters previously soaked in 10 mM isopropy113-t~-thiogalactopyranoside (IPTG), and incubated for 4 h at 37°C. Filters were blocked with 3% BSA in TBS for 30 min, washed with TBS, and incubated with a polyclonal anti-205K MAP antibody (Goldstein et al., 1986 ) in a 1:500 dilution for 2 h at room temperature. After washing with TBS, the secondary antibody, a mouse anti-IgG coupled to alkaline phosphatase (Sigma Chemical Co., St. Louis, MO), was applied in a 1:5,000 dilution. Positive phages were visualized with 5-bromo-4-chloru-3-indolylphosphate disodinm salt (BCIP) and nitro blue tetrazolium (NBT) (Sigma Chemical Co.) . Plaques in the region of the signal were resuspended in phage buffer (10 mM Tris, pH 7.5, 10 mM MgC12), replated, and rescreened with the same procedures. Three positive plaques were obtained and tested for the expression of the immunoreactive protein on Western blots. The insert of one phage was subcloned into the Bluescript-vector (pBS) and sequenced, the 740-bp insert was used as radioactive probe to screen a library of genomic DNA partially digested by San3A (kindly provided by Dr. B. Dujon, Institute Pasteur, Paris, France), and the clone F2B8 was isolated and sequenced. General molecular cloning techniques were as described (Maniatis et al., 1989) .
DNA Sequence Analysis
DNA sequencing was performed with the dideoxy chain termination method (Sanger et al., 1977) , using the Sequenase kit (UBS; United States Biochemical Corp., Cleveland, OH). Both strands of the genomic region containing the MHP1 gene were sequenced on average twice. Sequence data were assembled and analyzed with the Genetics Computer Group programs (Devereux et al., 1984) .
Computer Analysis of the MHP1 Sequence
Secondary structure analysis of the amino acid sequence of MHP1 was performed using the algorithms of Gamier et al. (1978) and Chou and Fasman (1978) . The protein databases PIR and Swissprot were searched with the entire Mhplp sequence using FASTA (Pearson and Lipman, 1988) . The sequence of Mhplp was compared directly to sequences of known MAPs using FASTA and PILEUP (Devereux et al., 1984) .
In Vitro Transcription-Translation
Coupled in vitro transcription and translation were performed with a transcription-translation kit (Promega Corp., Madison, WI) and [35S]methionine, according to the manufacturer's instructions. For each reaction 2 I~g of plasmid DNA were used. N1300 was a subclone in pBS containing the region from bp 656-3,662, and Nl121 was generated by restriction digestion. Construct Cl188 was generated by subcloning the PCR-amplified region from bp 3,562-4,368 into pBS.
MT-binding Assay
MT-binding assays were performed using porcine brain tubulin, purified by phosphocellulose chromatography. MTs were preassemblod and stabilized in the presence of 2 mM GTP and 20 p.m taxol as described (Vallee, 1982) . To test the MT-binding activity of the in vitro-translated proteins, the reaction mixture was centrifuged to precipitate nonsoluble material, protease inhibitors were added to the assembly reaction, and 4 Ixl of the in vitro translation reactions was added to assembled MTs in a total volume of 25 p~l. When Mhplp from yeast cells was tested, protease inhibitors were added to the assembly reaction before addition of 15 ~.1 total yeast protein extract in a total of 50 Ixl. Yeast cells (100 Ixg) were lysed in 100 p,! lysis buffer (100 mM Pipes-KOH, pH 6.9, 2 mM EGTA, I mM MgCI2) by vigorous vortexing (30 s) with glass beads and immediately used for the binding assay to minimize the degradation of Mhplp. Assembly reactions were centrifuged, pellets were rinsed with assembly buffer and recentrifuged, and supernatants and pellets were analyzed by PAGE.
Antibody Production and Purification
The COOH-terminal region of MHP1 from bp 3,562--4,368 was amplified by PCR, generating terminal NdeI sites, and cloned into the Ndel site of the His-tag expression vector pET-15b (Studier et al., 1990) , generating the plasmid pET-C1188, which was expressed in Escherichia coli. The apparent molecular mass of the His-tagged protein expressed by pET-Cl188 was 36-kD on SDS gels. The 36-kD protein, termed Cl188p, was purified on "His-bind" resin (Novagen, Madison, WI), and 100 p.g was injected subcutaneously into rabbits. The collected sera were centrifuged, and the supernatant was immunopurified on membrane-bound antigen as described (Olmsted, 1986) . 
Tubulin-binding Assay
Crude bacterial lysates from 200 ml cultures of E. coli expressing Cl188p from plasmid pET-C1188 or the His-tagged NH2-terminal region of MHP1, encoding amino acids 1-440, from plasmid pET-N440, were loaded onto His-bind resin columns. PET-N440 had been generated by cloning the PCR-amplified coding region of MHP1 with terminal Ndel sites into the NdeI site of pET-15. Deletion of the 3' XhoI fragment and religation allowed the creation of pET-N440. The Ni-columns were washed with standard His-bind binding buffer, equilibrated with 100 mM Pipes, pH 6.9, and loaded with a crude protein extract from 1 g of frozen S. cerevisiae strain Y501 prepared in 4 ml MT-binding buffer. Columns were washed extensively with Pipes and eluted with His-bind elution buffer. Column fractions were analyzed by PAGE and Western blotting.
Western Blots
Blotting procedures were performed as described (Ortega Perez et al., 1994) . The membranes were incubated at room temperature for 2 h with anti-MHP1 in a 1:200 dilution, or anti-205K MAP in a 1:500 dilution. The secondary antibody was alkaline phosphatase-conjugated anti-rabbit IgG (Sigma Chemical Co.), in a 1:5,000 dilution, and the reaction was visualized by BCIP and NBT (Sigma Chemical Co.). When a chemiluminescence detection method was chosen, anti-MHP1 was used in a 1:1,000 dilution, and goat peroxidase-coupled secondary antibody was used in a 1:5,000 dilution. Signal detection was carried out with the ECL kit (New England Nuclear, Boston, MA).
Indirect Immunofluorescence Microscopy
Yeast cells were harvested during exponential growth phase and prepared for immunofluorescence staining as described (Kilmartin and Adams, 1984) . The anti-ct-tubulin antibody YOLl/34 (Kilmartin et al., 1982 ) was used at a 1:20 dilution, and a 1:200 dilution was used for the polyclonal anti-MAP antibodies. To visualize MTs and Mhplp, TRITC-labeled secondary antibodies (Socochim, Pully, Switzerland) were used for tubulin, and FITC-labeled anti-rabbit IgG (Socochim) were used for the polyclonal anti-MHP1 antibodies. The DNA staining dye 4',6-diamidino-2-phenylindole (DAPI) and 0.1% p-phenylenediamine were added to the mounting medium to visualize the nuclear region. An alternative procedure was applied to better preserve the cytoplasmic localization of Mhplp; the fixation and digestion of cells was 30 min each, and the time of antibody incubation was reduced to 50-60 rain.
Epitope Tagging of Mhp lp
The antigenic myc-tag (Munro and Pelham, 1984) was PCR amplified, generating terminal BamHI sites, and cloned into the BamHI site located between the GAL promoter and the MHP1 sequence on plasmid pMACPst (Table II) , generating pMACmyc-Pst. Constructs were sequenced to confirm correct insertion and conservation of the open reading frame (ORF). Y507 cells, transformed with plasmid pMACmyc-Pst (Tables I  and II) , were grown in selective medium overnight and for another 10 h in selective medium containing 1% galactose or 1% glucose. For immunofluorescence microscopy, the tagged epitope was detected with monoclonal 
Disruption of MHP1
The mhpl-Al allele (see Fig. 6 ) was generated by excising a l.l-kb EcoRI fragment from the MHP1 coding region, from amino acid residues 818-1,210 (see Fig. 2 A), and inserting a 0.9-kb EcoRI fragment containing the TRP1 + marker. The MHP1-TRP1 construct was excised from the plasmid with SalI (one genomic SalI site and one site in the plasmid linker) and transformed into the diploid Trp-strain Y501 (Rothstein, 1983) . Trio + transformants Y5ff2 were analyzed for correct insertion of the marker gene by PCR and Southern blot analysis. The mhpl-A2::URA3 mutation was generated by inserting the URA3 + marker between the two PstI sites at position 1667 and 1679, respectively (see Fig. 2 A) . A 4.5-kb SalI-HindlII fragment was excised and used to generate the heterozygous Ura + cells Y105. Insertion of the marker gene was confn'med on Southern blots. mhpl-A4::TRP1 was generated by cloning a PvuII fragment containing the TRP1 + marker gene between two NcoI sites (positions -2 and 1833) within the MHP1 gene. A 3-kb NotI-SalI fragment (both sites in the linker sequence of pBS) was excised and used to transform Y501 cells, and Trp + transformants Y521 were selected. The correct insertion of the marker gene was confirmed by PCR. The mhpl-A5::HIS3 mutation was generated by excising the PstI-EcoRI fragment (from position 1667 to 3626) and replacing it with a PstI-EcoRI fragment containing the HIS3 + marker gene. A 3.5-kb SalI-SalI fragment (one SalI site near the 5' end of MHP1 and one SalI site in the linker sequence at the 3' end of the MHP1 gene) was used to transform Y501 cells, and His + transformants Y531 were selected and analyzed for insertion of the marker gane by PCR. The mhpl-A6::kan" allele was generated by PCR amplifying the kanr gene from the plasmid pFA6-kanMX4 (Wach et al., 1994) , using the primers 5' CACTTAAATACGCAAAATATACAAGATAGCCCTACAACT-GCTCCATGCAGCTGAAGCITCGTACGC 3' and 5' TFAT'ITAGT-ACTACTGTTCCGCGCATCCTGGATITFGTCTAGCACGCATAGG-CCACTAGTGGAT 3'. The resulting DNA fragment contained terminal ends homologous to 45 bp flanking the respective translation start and stop sites of MHP1. Transformants were selected on plates containing rich medium supplemented with 100 mg of G418 per liter. Six independent transformants were obtained that contained the mhpl-A6::kan r allele correctly substituted at the MHP1 locus as analyzed by PCR.
Complementation and Overexpression Experiments
To complement the mhpl-A6::kan" allele with MHP1, we generated pMAC-MHP. The region including nucleotides 1-670, downstream from the unique SalI site, was amplified by PCR with terminal BamHI sites and cloned into the BamHI site of pMAC-80, a derivative of pRS315 (Sikorski and Hierter, 1989) , into which we had inserted the GAL promoter (Table  II) . The remaining 3.6 kb of the MHP1 coding region from the SalI site at bp 752 to the 3' end (SalI site in the multicloning site of pBS) were inserted into the SalI site, and correct orientation was determined by restriction digestion analyses. Heterozygous mhpl+/mhpl-A6::kan r cells Y561 were transformed with pMAC-MHP or pMAC-Pst (Table II) , and Leu + and G418-resistant cells were spornlated and dissected on glucose-and galactose-containing plates. In 8 out of 12 tetrads, two colonies of normal size and two small colonies could be observed after 4-5 d of incubation at 30°C, with the normal-sized colonies unable to grow on (3418. All small colonies were Leu + and resistant to G418. Colonies growing from individual spores were followed by microscopic inspection for 7 d. Leu + and G418-resistant cells from glucose plates were grown in liquid medium containing either glucose or galactose, and aliquots were taken after 4 and 20 h of growth and prepared for immunofluorescence.
Overexpression of the 3' half of MHP1, designated mhpl-A3, was performed with the clone pMAC-Pst. The mhpl-A3 allele was generated by cloning the region from bp 1,769-4,339 of the MHP1 gene between the PstI and SalI sites of pMAC-80 (Table II) . The correct insertion was verified by restriction analysis. Y501 and Y502 cells were transformed, and Leu + or Leu + Trp + lines were generated and designated Y505 and Y506, respectively, pMAC-Bam was generated by cloning a BamHI-PstI fragment (bp 657-1,684) of MHP1 between the BamHI and PstI sites of pMAC-Pst. Y501 cells were transformed with pMAC-Bam and Leu + transformants were designated Y508. For pheuotypic analysis, the cells were grown in selective medium overnight, and 5 to 20 h in selective medium and 2% galactose.
Rescue experiments of the mhpl-A1 deletion mutation were attempted with the 4.5-kb cDNA of the Drosophila 205K MAP (lrminger-Finger et al., 1990) , which was cloned into the NotI site of the yeast multicopy expression vector pADNS (Colicelli et al., 1989) , containing the alcohol dehydrogenase (ADH) promoter and the selectable marker LEU2 +, generating plasmid pADN-205 (Table II) . The heterozygous mhpl+/mhpl-A1 cells Y502 and mhpl+/mhpl-A6 cells Y561 were transformed with the resulting plasmid pADN-205. Leu + transformants were selected and used for tetrad analysis. Silencing of the ADH promoter was performed in medium containing 2% galactose instead of glucose. Cell growth was quantified by growing cells for 12-20 h in glucose, and then the OD~00 was measured. Cells were diluted to an OD~0 of 0.05 and growth was monitored in glucose and in galactose.
Results
Cloning of MHP1
To clone genes encoding yeast MAPs, a eDNA expression library was screened with a previously produced antibody preceded by a putative CAAT box and a TATA box at positions -52 and -27, respectively ( Fig. 2 A) . The coding region of MHP1 is identical with ORF YJL042W on chromosome X and is separated by 344 noncoding bp from NSP1 (Hurt, 1988) and ~1,300 bp from GYP6 (Strohm et al., 1993) .
DNA and Protein Sequence Analysis
No significant homologies with other proteins were found when the EMBL and Swissprot databases (release May 1996) were searched with the MHP1 sequence. From amino acid residues 128-137, nine histidines are encoded that could have a function in metal binding. With sequence analysis programs for the detection of specific motifs, a possible EF hand motif was identified between amino acid residues 615 and 629 ( Fig. 2 A) . When the MHP1 protein sequence was compared directly with protein sequences of known MAPs using PILEUP, MAP4, MAP2, tau, and Mhplp could be aligned and showed a significant similarity in a region close to the COOH terminus, including residues 1,211-1,266 in Mhplp (Fig. 2 B) . Within this region, Mhplp has between 23 and 32% identity or between 33 and 38% similarity with the sequences of the other MAPs. The highest similarity score was found with MAP4, and the lowest with tau. Included in this region is (from residues 1,234-1,266 of Mhplp) one repeat of the AP motif common to tau, MAP2, and MAP4 (Lee et al., 1988; Lewis et al., 1988; Aizawa et al., 1990; Chapin and Bulinski, 1991; West et al., 1991) . Some 50 residues downstream from the putative MT-binding motif, a nuclear localization signal (NLS) consensus sequence (Roberts, 1989 ) is present ( Fig. 2 A) . MHP1 encodes a hydrophilic protein, with a calculated isoelectric point (pI) of 6.9, but is composed of alternating basic and acidic regions within which the calculated pI values range from 10-12 and from 4.5-5, respectively ( Fig.  1 B) . The highest concentration of charged amino acids is observed within acidic and basic regions near the COOHterminal end of Mhplp. The NH2-terminal and the COOHterminal regions of Mhplp are very proline rich, typical of extended protein structures, but between residues 1,070 and 1,150 a propensity for the formation of ot helices is predicted (Chou and Fasman, 1978; Garnier et al., 1978) . A total of 52 potential phosphorylation sites for the cAMP-dependent kinase (Edelmann et al., 1987) , the calcium-phospholipid--dependent kinase (Gonzales et al., 1989) , the CaZ+-calmodulin-dependent kinase (Pearson et al., 1985) , and the casein kinase II (Diaz-Nido et al., 1988) are situated within the NHz-terminal two-thirds of Mhplp, but only two potential sites are localized within the COOHterminal domain (residues 1,201-1,398) of the protein (Figs. 1 B and 2 A) .
Identtfication of Mhp lp with Anti-MHP1 Antibodies
To obtain Mhplp-specific antisera, clone pET-Cl188 encoding amino acids 1,188-1,398 was expressed in E. coli, and antibodies were generated against the His-tagged 36-kD protein C1188p. The antiserum was tested on Western blots and recognized the purified samples of Cl188p and Cl188p in protein lysates of induced bacterial cultures. On Western blots of whole cell extracts from S. cerevisiae, a 200-kD protein as well as smaller proteins of ~<46 leD were consistently recognized by anti-MHP1 (Fig. 3 A; Y501 and Y502) when 20 i~g of total protein extract was loaded.
The amount of anti-MHP1 reactive protein is reduced in mhpl+/mhpl-A1 heterozygous cells Y502 compared with mhpl + cells Y501 (Fig. 3 A) . When an equal amount of protein from Y509 cells overproducing Mhplp from a multicopy plasmid was loaded, the 200-kD protein was substantially increased on Western blots, but also a protein of 150 kD could be detected. The full-length MHP1 gene expressed in E. coli also migrates at 200 kD, supporting the conclusion that full-length Mhplp is identical with the 200-kD band (data not shown). Less intense staining was observed for proteins of 230, 90, 60, and 46 kD. After longer exposure times, the same patterns of proteins were observed in the protein extracts from Y501 and Y502 cells. To test the specificity of the antibody reaction, competition experiments were performed using purified Cl188p. The addition of 1-10 ~g/ml, purified Cl188p was tested, and 5 ixg/ml was found to be sufficient to compete the antibody recognition of Mhplp on Western blots. When 5 ixg/ml purified Cl188p was added during the antibody incubation, the 200-kD as well as the other proteins observed in Y509 cells could be completely competed with Cl188p ( Fig. 3 A, b) . These proteins presumably contain the COOH terminus against which anti-MHP1 was raised, and are either isoforms of Mhplp and/or degradation products, although the caveat remains that anti-MHP1 might recognize an epitope that is present on other proteins. The observed size of 200 kD for Mhplp is considerably larger than its calculated molecular mass of 154 kD, but it could result from phosphorylation and abnormal migration as a result of the acidic portions of the protein.
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2,:,a ace*~cacraA,z.r a~an-r TTT~CCTWlTrr'r w~Te'rr (Fig. 3 B,  lanes I and 2) , but only the 200-kD protein copurified with yeast tubulin on a DEAE column (Bellocq et al., 1992) . When heat-stable yeast proteins were tested with anti-MHP1 and anti-205K MAP, the 200-kD protein was also detected by both antisera (Fig. 3 B, lanes 3 and 4) .
Mhplp Has MT-binding Activity In Vitro
To determine whether Mhplp binds to MTs in vitro, MTbinding and cosedimentation experiments were carried out. Total yeast proteins were incubated with preformed MTs and centrifuged, and supernatant and pellet fractions were analyzed on Western blots probed with anti-MHP1 (Fig. 4 A, a) tion reaction in the pellet fraction, which was considered specific binding, while the Nl121 protein, terminating at residue 1,121, showed virtually no binding and >80% of the radioactivity remained in the supernatant (Fig. 4 A, b) . Traces of radioactive protein in the pellet were considered as background, since similar amounts were observed in control experiments with unrelated proteins. The N1300 construct, terminating after residue 1,300, showed an intermediate binding with approximately the same amount of radioactive protein in the pellet and in the supernatant fraction, although it contained the sequence homologous to the tau-repeat. These experiments suggest that the COOH-terminal end of Mhplp that is contained in Cl188 More than 80% of radioactive protein in the pellet lane was considered to be MT binding (+), >80% in the supernatant was not binding (-), and 50% in the supernatant and 50% in the pellet fraction was (+/-) binding.
but not in N1300 may be needed for efficient binding or, alternatively, that the folding of a putative binding domain may be disturbed in the N1300 deletion. To confirm by an independent approach that the COOH-terminal domain of Mhplp contains a region that promotes MT-b'mding, we took advantage of the His-tag purification procedure of proteins expressed from the pET-15b vector in E. coli. We used the COOH-terminal peptide Cl188p, immobilized on Ni-columns, to identify proteins that interact with this region of Mhplp. Ni-columns containing bound Cl188p were saturated with crude yeast protein extracts in MT-binding buffer, washed, and then eluted with the standard metal-chelation buffer. Several proteins bound to the Cl188p-eolumn. A 48-kD protein was identified as tubulin on Western blots probed with antibodies against a-or g-tubulin (Fig. 4 B) . in control experiments, crude yeast protein extracts were loaded on a Ni-column that was preabsorbed with either a protein extract from bacteria not expressing exogenous genes or a protein extract from bacteria transformed with the His- tagged NH2-terminal part of Mhplp, including amino acid residues 1--440. In both cases, some proteins were bound, but the binding of tubulin or MTs was only observed after preabsorption with the bacterial extract producing Cl188p (Fig. 4 B, right) . Hence, the MT-binding activity was confirmed to reside principally in the COOH-terminal region of Mhplp containing the AP-homologous sequence.
Immunolocalization of Mhp lp
Immunolocalization of Mhplp with anti-MHP1 was carried out in Y501 and Y509 cells that carry MHP1 from a multicopy plasmid (Table II) . Less intense staining was observed in Y501 cells than in Y509 cells that are presented (Fig. 5, A-C) . Cytoplasmic MTs were decorated in ~60% of interphase cells (Fig. 5, A-C) . In mitotic cells, short metaphase spindles as well as elongating spindles were stained (Fig. 5, D-F) . Cytoplasmic staining was also observed in Y509 cells when an altered fixation and labeling procedure was applied (see Materials and Methods). Immunolocalization of Mhplp in cells transformed with a myc-tagged MHP1, on the plasmid pMACmyc-Pst (Table   II) , confirmed the localization of Mhplp on MTs (Fig. 5,  G-/) . No staining was observed with anti-myc antibodies in Y501 cells (Fig. 5, J-L) , demonstrating that anti-myc staining was not due to fluorescence spill-over.
MHPI Is Essential for Cell Growth
Since Mhplp was shown to bind to MTs in vitro, it was of interest to determine whether MT structure or function was disturbed in cells lacking MHP1. We constructed a series of disruption alleles of MHP1 by replacing different regions of the ORF with marker genes (Fig. 6 A) . Deletion of the entire coding region of MHP1 (mhpl-A6::kan r) was performed in diploid Y501 cells, and tetrads of six independent transformants were dissected. The mhpl-A6::kan r mutation led to lethality, and the kan+/kan -phenotype segregated 2:2 in all complete tetrads, the surviving spores being unable to grow on G418. The deletion of a COOHterminal region from amino acids 818-1,210 also resulted that the NH2-terminal 818 amino acids encoded on the mhpl-AI::TRP1 allele are not sufficient for viability.
Surprisingly, the interruption of the ORF after amino acid 558 by the insertion of the URA3 ÷ marker gene led to viable haploid cells (Fig. 6 ). (Fig. 7 A) through a few cell divisions, but they died at stages of 8 to 32 cells. The time needed for germination was variable for different spores and explains the size differences of the colonies (Fig. 6 B) . The heterozygous cells showed a reduced growth rate in rich medium. Analysis of asynchronously growing Y502 and Y561 cells by DAPI and antitubulin staining showed 12% of the cells with short or long spindles and divided nuclei, compared with 2-3% routinely observed for wild-type cells under the same conditions, indicating that they are arrested or slowed during mitosis (data not shown).
Altered MT Phenotypes Induced by MHP1 Overexpression Mutations
Since the heterozygous deletion mutations of MHP1 showed a gene dosage effect, we investigated whether overexpressed MHP1, or deletion-bearing alleles of MHP1, would lead to a dominant phenotype. Y509 cells that express MHP1 constitutively from a multicopy plasmid (pYEP-MHP) exhibit a reduced growth rate (Fig. 8 A) . The analysis of MT structures in asynchronously growing Y509 cells showed that the amount of cells with elongated spindles and divided nuclei was <1%, while the parental strain Y501 grown under similar conditions contained 2-3% of were probed with a 700-bp probe from the 5' end and a 600-bp probe from the 3' end of MHP1 (see Fig. 1 A) . In mhpl-A2:: URA3 haploid cells Y106, the 5'-end probe and the 3'-end probe detected different mRNAs (arrows). cells with short or long spindles and divided nuclei. In addition, Y509 cells showed an increased cell volume (150-200% of diploid wild-type cells), many abnormally long MT filaments emanating from one SPB, increased nuclear. DNA staining, and small patches of DAPI-stained material observable in the cytoplasm (Fig. 8 B, a) . In 6% of the cells, bud formation occurred but no spindle was formed. The increase in length and number of MTs in Y509 cells, as a consequence of increased expression of MHP1, is compatible with the role of Mhplp as a positive regulator of MT stability.
A different phenotype could be induced by the overexpression of the COOH-terminal portion of Mhplp. The region encoded on pMAC-Pst (Table II) , designated mhpl-A3, was transformed into homozygous mhpl ÷ cells and into mhpl+/rnhpl-A1 heterozygous cells, generating Y505 and Y506 cells, respectively. Cells were grown in medium containing either glucose, galactose, or raffinose (a sugar derepressing the GAL promoter and leading to less expression than galactose). The induction of mhpl-A3 was monitored on Western blots, and the expression of a 90-kD protein, as had been identified in mhpl-A2 cells under conditions of unstimulated expression (see Fig. 7 B) , could be observed in Y505 and Y506 when cells were grown in galactose or raffinose (data not shown).
The expression of mhpl-A3 provoked a negative effect on growth rate. While control cells Y502 reached saturation after ~24 h with a doubling time of 3 h in media containing galactose, for transformed Y505 and Y506 cells, longer times were required to reach saturation when grown in galactose-containing media, with generation times of 4.5 and 6 h, respectively. When media containing increasing amounts of galactose and decreasing amounts of glucose, or the partial inducer raffinose, were used, the growth rates of Y505 and Y506 cells were correlated with the galactose or raffinose content in the media.
To determine the consequence of the expression of mhpl-~3 on MT structure and function, we analyzed asynchronously growing cultures by immunofluorescence mi- croscopy with anti-tubulin staining. When Y505 and Y506 cells were grown in raffinose or galactose, their progression through mitosis was slowed down in various stages of mitosis. With the activation of the GALl0 promoter, an accumulation of cells with large buds, monopolar or short bipolar spindles, unseparated nuclei within the mother cells or at the bud neck, and cytoplasmic MTs extended into the daughter cells (but very sparse or not detectable) could be observed (Fig. 8 B) , while the number of cells with separated nuclei and long spindles decreased with increased expression of mhpl-d3. The percentage of cells exhibiting this phenotype was correlated with the level of mhpl-Zl3 expression (higher when cells were grown in galactose than when grown in raffinose) and with the time after induction (Table III) . After 20 h of induction, 60% of the Y505 cells were large budded and had short or monopolar spindles formed. Only 5% of the cells were large budded with elongated spindles and nuclear migration that had proceeded into the bud. In the heterozygous Y506 cells, we observed 78% large-budded cells of which 73% had short or monopolar spindles. The comparison of the cell cycle arrest phenotype of Y506 cells after different times of rnhpl-zl3 induction demonstrates that a short bipolar spindle can be formed, but spindle elongation might be hampered. In control cells transformed with pMAC-MHP overexpressing the entire MHP1 gene or transformed with pMAC-80 (Tables I and II) , no such phenotypes were observed. The NH2-terminal 561 amino acid residues of MHP1 therefore appear to be required for the function of Mhplp during progression through anaphase.
MHP1 Null Allele Complemented with MHP1 and with mhp l-A3
To further characterize the null phenotype of the MHP1 deletion alleles, we have performed rescue experiments with MHP1 on plasmids under the control of inducible promoters, pMAC-MHP contains full-length MHP1 under the GALl0 promoter, while pMAC-Pst contains the 3' region of the gene designated mhpl-A3. With both plasmids, the lethal phenotype of the haploid mhpl-A6::kaff cells could be partially rescued, giving rise to small colonies (Fig. 9 A) . The fact that mhpl-A3 could also partially compensate for the null mutation of MHP1 is consistent with the finding that the insertion mutation mhpl-A2 is viable, and confirms that the expression of the region encoding amino acids 560-1,398 is sufficient for vegetative growth. With both plasmids, rescue could only be observed when dissections were carried out on plates containing glucose, and tetrads dissected on plates containing galactose gave rise to only two colonies of normal size. Microscopic inspection of the spores on galactose-containing plates, at intervals of 1 d, showed that all cells sporulated and divided initially with the same doubling times until they reached the ,'-q6-32 cell stage. Two colonies slowed down in their doubling time and finally stopped growing. We presume that the overproduction of Mhplp under the GALl0 promoter was toxic to the cells, and that leaky expression of MHP1 from the GALl0 promoter allowed reduced transcription and translation of MHP1 and mhpl-A3 in the small-sized colonies growing on glucose plates.
MHPI Expression Is Required for Sufficient Formation
of Mrs
To examine the MT phenotype in the MHP1 null allele, we have generated haploid mhpl-A6 cells Y564, complemented with inducible MHP] on the plasmid pMAC-MHP. When Y564 cells were grown under noninduced conditions, Mhplp was below detectable levels when tested on Western blots or by immunofluorescence analy- Table IlL Cell Cycle Arrest of mhpl-A3 Mutant sis. However, since it became apparent that leaky expression of MHP1 from the GALl0 promoter was sufficient for cell growth (Fig. 9 A) , we analyzed the phenotype of Y564 cells after growth in glucose and galactose. Immunostaining with anti-tubulin antibodies and DAPI revealed that the rescued haploid mhpl-A6::kan r cells contained few MTs (Fig. 9 B) . At least 15% of the cells formed small or large buds, but only weak staining of mitotic spindles could be observed. However, the diffuse staining of tubulin in the cytoplasm was increased. When cells were grown for several hours in galactose, which led to a reduced growth rate, long MT fibers were formed in 5% of the cells, in N10% of the cells weak staining was observed, and in the majority of cells neither MT nor DAPI staining was detectable. The parental diploid cells Y562 prepared under identical conditions showed intense MT staining in interphase and mitotic cells (Fig. 9 B) . tion, no rescue was observed. To test possible effects of the pADNS plasmid, control experiments were also performed with the pADNS plasmid alone, but no rescue was observed. These results indicate that the partial rescue of the mhpl-A1 and mhpl-A6 mutations depends specifically on the expression of 205K MAP. From the Trp+Leu + haploid cells, strain Y504 was generated and growth was analyzed under conditions that permitted or suppressed the expression of 205K MAP. After depriving the cells of glucose to silence the ADH promoter, no growth was observed for Y504 cells, while Y502 cells could grow with galactose instead of glucose as a carbon source, although initially at a slower rate (Fig. 10 A) . We conclude that the viability of haploid mhpl-A1 cells is partially restored by the expression of the 205K MAP, and that 205K MAP and Mhplp share some functional similarity. Analysis of MT structures in Y504 cells displayed an abnormal increase of cytoplasmic MTs in number and length. Y504 cells also showed an accumulation of cells with elongated (25%) and short spindles (15%). The elongated spindles contained thicker bundles of MTs than comparable wild-type cells, and the number and length of cytoplasmic MTs that emanate from the SPBs were increased. The axis of the mitotic spindle was altered in some cases, and multinucleated cells with multiple spindles could be observed (Fig. 10 B) . In addition, the nuclear DNA staining appeared diffuse or fragmented and in some cases, no nuclear staining could be observed. Similar phenotypes were Mhplp possesses structural features in common with other known MAPs. Its estimated size on SDS gels is 50% larger than its calculated molecular weight, an observation made for other highly charged MAPs (Irminger-Finger et al., 1990; West et al., 1991) . It is possible, however, that the 230-, 200-, and 150-kD proteins that are recognized by anti-MHP1 antibodies are isoforms of Mhplp generated by posttranslational modification. Mhplp is highly charged and the putative MT-binding domain is followed by an acidic COOH-terminal region, which is similar to the organization of tau and 205K MAP (Lee et al., 1988; Irminger-Finger et al., 1990) . In contrast with MAP2, tau, and 205K MAP consisting of an acidic NH2-terminal portion, a basic domain containing the MT-binding region, and in the case of tau and 205K MAP an acidic COOHterminal region, Mhplp contains alternating acidic and basic regions, and its acidity gradually increases from the NH2-terminal to the COOH-terminal end. However, the density of potential phosphorylation sites gradually decreases from the NH2-terminal to the COOH-terminal end (Fig. 1 B) and could lead to more negative charges within the NH2-terminal half of the protein.
Phosphorylation has been characterized as an important mechanism for the regulation of the interaction of MAPs with MTs. In contrast to tau, MAP2, and 205K MAP, the potential kinase target sites on the amino acid sequence of Mhplp localize within the NH2-terminal two-thirds of the protein with fewer sites in the COOH-terminal portion containing the putative MT-binding region. It is therefore possible that MT binding in Mhplp is less influenced by phosphorylation than by other functions residing in the NH2-terminal portion of Mhplp. An important function for the NH2-terminal domain of Mhplp is also suggested by the phenotype induced by the rnhpl-A3 allele (Fig. 9) .
We have demonstrated that the region of Mhplp sufficient and essential for MT binding is located within the COOH-terminal 210 amino acid residues of Mhplp. The localization of the AP homologous sequence motif within this region is consistent with its role in MT binding. However, the region found to be homologous to the AP motif is less basic than other AP sequences, although flanked by sequences containing basic residues (Figs. 1 B and 2) . It is conceivable that these adjacent basic sequences participate in MT binding in Mhplp or that the binding is achieved without a predominantly basic charge, as was reported for binding motifs of other MAPs (Hemphill et al., 1992) . In support of this idea is the finding that an interrepeat region of the AP repeats in tau has higher MT affinity than a single repeat (Goode and Feinstein, 1994) . A significant contribution of the sequences outside the AP motif, which was also reported for MAP4 (Olson et al., 1995) , might explain why for Mhplp a single repeat could be sufficient for MT binding. The reduced binding activity of the deletion N1300, containing the AP-homologous sequence but not the entire COOH terminus of Mhplp, could be due to a participation of sequences close to the COOH terminus to MT binding. It is also possible that the protein folding of the deletion N1300 is altered when the COOH terminus is missing.
The generation of Mhplp-specific antibodies permitted the identification of Mhplp as a 200-kD protein on Western blots comigrating with bacterially produced Mhplp. Minor bands of 150, 90, and 60 kD also react with anti-MHP1 and are increased in Y509 cells overproducing Mhplp. These proteins could be degradation products, isoforms, or products of differential transcription and translation. The former possibility would be consistent with the expression of a 2.8-kb mRNA observed in wildtype cells, which hybridized to the 3'-end probe of MHP1 (Fig. 7 A) . The differential transcription and/or translation could be a regulatory mechanism for the expression of MHP1 gene products encoding different functions. The localization of the anti-MHPl-reactive epitope to cytoplasmic and nuclear MTs is consistent with MT-binding experiments. However, since anti-MHP1 was generated against the COOH-terminal peptide Cl188p, we cannot exclude that the staining observed in immunofluorescence analyses is due to cross-reaction with isoforms of Mhplp <200 kD, as observed on Western blots.
Indirect evidence that differential transcription and translation could lead to functional products comes from the viable mhpl-A2 mutation, derived from an insertion in the NH2-terminal half of the protein-coding region, that disrupts the ORF after residue 557. It seems likely that mhpl-A2 mutant cells express both NH2-and COOH-terminal truncation products of MHP1, since two separate transcripts are detected. The translation of a COOH-terminal 90-kD protein, detected with anti-MHP antibodies in mhpl-A2 cells (Fig. 7 B) , could be initiated at one of the candidate methionine initiation codons located at positions 598 and 612 (Fig. 2 A) . The mhpl-A4 mutation deleting coding sequences from residues 1--613, including the two potential translation initiation codons, is lethal in haploid cells. Also, the mhpl-A5 mutation, deleting residues downstream of the URA3 ÷ insertion site in the mhpl-A2 mutation, results in lethality in haploid cells, supporting the conclusion that transcription initiation can occur at positions 598 or 612. Viability of the null mutant could also be restored with plasmid pMAC-Pst (Fig. 9 A) containing the region downstream from amino acid position 561, demonstrating that the COOH-terminal region is sufficient for viability without the NH2-terminal portion of the gene expressed separately.
The results of gene disruption experiments and in vitro MT-binding experiments suggest that Mhplp is organized in a COOH-terminal domain (residues 821-1,398) essential for MT binding, and an NH2-terminal domain (residues 1-561) important for proper function of Mhplp, which is absent in the mhpl-A3 mutation. Deleting the region of MHP1 that includes the domain essential for MT binding leads to lethality in haploid cells (Fig. 6 ), but the NH2-terminal deletion allele mhpl-A3 can partially compensate lethality of the complete null allele, demonstrating that mhpl-A3 provides sufficient MHP1 function for viability (Fig. 9) . The overexpression of the mhpl-A3 allele leads to reduced growth with a specific phenotype of heterogeneously arrested cells at different stages of mitosis mostly before the onset of anaphase. The number of mutant cells is correlated with the expression level of the mutant protein. In contrast with mutants effecting SPB duplication, such as karl and cdc31 (Vallen et al., 1994) , mhpl-A3 cells arrest at various times of spindle formation, and it is the number of cells with elongated spindles and divided nuclei that becomes more reduced when the expression of mhpl-A3 is increased (Table III) . The hetero-geneous phenotype of inhibition of the progression through anaphase strongly suggests a structural defect compatible with a role in MT stabilization and/or formation.
A different phenotype was observed with the overexpression of the entire MHP1. The additional production of Mhplp results in increased formation and/or stabilization of cytoplasmic MTs. It is possible that the protein encoded on rnhpl-A3 is missing a signal that retains it in the cytoplasm or that the truncated form is more efficiently transported to the nucleus interacting with nuclear MTs. Reports from a number of laboratories demonstrate that the interaction of MAP4-type proteins with MTs is regulated during the cell cycle by phosphorylation by specific kinases ( 
